Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cytoskeletal 39 (KRT39) is a member of the type I (acidic) keratin family of intermediate filament proteins, primarily expressed in the skin and hair follicle, especially in the upper hair cuticle and cortex. It functions as a structural component, contributing to the integrity and mechanical resilience of hair and skin. KRT39 is not considered a receptor, enzyme, or classical therapeutic target, and there is currently no evidence it plays a significant role in common human diseases or is targeted by any drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cytoskeletal 39 (KRT39).